NIH Governance: Board Chair Questions Vaccine Clinic's Reputation Risk

Jack Leslie, chair of the board overseeing the National Institutes of Health Clinical Center Research Hospital, issued a direct warning that Health Secretary Robert F. Kennedy Jr.'s new vaccine injury clinic poses a threat to the institution's reputation. Leslie delivered this assessment during a recent regularly scheduled board meeting, marking a notable departure from the group's usual procedural routine.

The clinic launched recently at a ribbon-cutting ceremony attended by Kennedy and other high-ranking Trump administration officials. During the event, a panel of individuals identified as vaccine injured sat behind placards with that specific label. Leslie argued that the high-profile nature of the launch, combined with the secretary's public anti-vaccine stance, creates a risk for a facility widely known as a "house of hope." That nickname stems from its role as a final destination for patients with rare conditions who have exhausted other medical options.

Leslie spent approximately six minutes on the issue, prioritizing the critique over the standard agenda. He stated that silence from the advisory board would constitute a failure of its duties. "But I think that that would be a failing as an advisory board if we were silent," Leslie said. He clarified that his objection was not to the scientific study of vaccine harms, noting that serious reactions are rare but real. He added that people who believe they have been injured should be taken seriously.

Hospital CEO Jonathan Green supported Leslie's account during the meeting. Green noted that the NIH has researched vaccine safety and efficacy for decades and that this work continues. He described the new clinic as a single individual "protocol" rather than a major structural change. Green emphasized that the clinic operates within the existing framework of the hospital's ongoing research activities.

The practical details of the clinic reveal a disconnect between its public presentation and its operational scope. The NIH already maintains a center dedicated to studying vaccine injuries. Kennedy's new clinic does not come with additional funding or extra clinic space. This lack of new resources stands in contrast to the ceremonial launch that featured prominent government figures and public testimonials.

Leslie's focus on reputation contrasts with Green's technical description of the clinic as a modest addition to existing work. For the board, the concern is how the association with the Health Secretary's public persona might affect a hospital serving some of the most vulnerable patients in the country. The meeting concluded with these remarks, leaving the board to manage the balance between the clinic's research value and its symbolic impact.